Stock Screener App

Gratuito - Play StoreApp Store

Installare Installare

NUVB

$4.592.24%-0.105

Dopo l'orario di chiusura: 4.62+0.04 +0.76%

Nuvation Bio Inc (NUVB)

Date: O: H: L: C: Vol:

Nuvation Bio Inc Borsa (NUVB) Ultime notizie

Nuvation Bio to Expand Pivotal Phase 3 SIGMA Study of Safusidenib for IDH1-Mutant Glioma to Six European Countries - Investing News Network

Nuvation Bio expands glioma drug trial to six European nations By Investing.com - Investing.com India

NUVB Q3'26 Earnings: revenue estimate is 34.39M USD - TradingView

Nuvation Bio Inc. Estimates – NYSE:NUVB - TradingView

Nuvation Bio And 2 Other Top Penny Stocks - Simply Wall Street

Nuvation Bio To Report Third Quarter 2026 Financial Results And Provide Business Update On November 4, 2026 - TradingView

Nuvation Bio to Report Third Quarter 2026 Financial Results and Provide Business Update on November 4, 2026 - AOL.com

Nuvation Bio to Report Third Quarter 2026 Financial Results and Provide Business Update on November 4, 2026 - TradingView

Nuvation Bio to Report Third Quarter 2026 Financial Results and Provide Business Update on November 4, 2026 - Moomoo

October 2026's Top Insider-Owned Growth Stocks - Simply Wall Street

Citizens reiterates Nuvation Bio stock rating on launch execution - Investing.com

Nuvation Bio And 2 Penny Stocks To Watch - Yahoo Finance

Nuvation Bio Inc. (NUVB) Latest Stock News & Headlines - Yahoo Finance - Yahoo! Finance Canada

End Brain Cancer Initiative Partners with Nuvation Bio on SIGMA Phase 3 Grade 2/3 Glioma Brain Cancer Study Education - EIN News

3 Promising Penny Stocks With Market Caps Over $200M - Simply Wall Street

Nuvation Bio Inc. (NUVB) Stock Price, News, Quote & History - Yahoo! Finance Canada

Nuvation Bio Inc. (NUVB) stock price, news, quote and history - Yahoo Finance Singapore

Nuvation Bio Inc. (NUVB) stock price, news, quote and history - Yahoo Finance UK

What Makes Nuvation Bio (NASDAQ:NUVB) Stand Out in Nasdaq Biotech? - Kalkine Media

Elite Penny Stocks To Watch In October 2026 - Simply Wall Street

Citigroup Initiates Nuvation Bio at Buy With $12 Price Target - Moomoo

Nuvation stock, Jazz stock gain new Buys at Citi (NUVB:NYSE) - Seeking Alpha

Citigroup Initiates Nuvation Bio at Buy With $12 Price Target - Yahoo Finance

Nuvation Bio Inc. (NUVB): Investor Outlook With A 115.82% Potential Upside - DirectorsTalk Interviews

Why Is Nuvation Bio Stock Gaining Thursday? - Benzinga

Nuvation Bio stock gains on FDA label update for IBTROZI - Investing.com

Nuvation Bio Inc. (NUVB) latest stock news and headlines – Yahoo Finance - Yahoo Finance Singapore

Nuvation Bio stock rises on Ibtrozi label update (NUVB:NYSE) - Seeking Alpha

Nuvation Bio Announces FDA Approval of Supplemental New Drug Application for IBTROZI® (taletrectinib) with Updated Duration of Response in TKI-Naïve Advanced ROS1-Positive Non-Small Cell Lung Cancer - PR Newswire

Nuvation Bio Inc. (NYSE:NUVB) Wins FDA OK To Add ~50-Month DOR To IBTROZI Label - TradingView

Nuvation Bio (NUVB) Reports IBTROZI Efficacy Across ROS1 Lung Cancer Subgroups - Yahoo Finance

Nuvation Bio Announces New Analyses Reinforcing the Durable, Consistent Efficacy of IBTROZI® (taletrectinib) Across Key Patient Subgroups in Advanced ROS1+ NSCLC at 2026 World Conference on Lung Cancer - PR Newswire

Nuvation Bio (NUVB) Stock Looks Stretched Despite Its 354% Three Year Run - webull.com

NUVB: IBTROZI dominates ROS1 with best-in-class efficacy, while safusidenib advances across glioma subtypes - TradingView

Nuvation Bio at 12th Annual Cantor Fitzgerald Global Healthcare Conference: pipeline gains - Investing.com

NUVB: IBTROZI’s superior efficacy and safety drive rapid market share gains, with a strong pipeline advancing - TradingView

Nuvation Bio at 12th Annual Cantor Fitzgerald Global Healthcare Conference: pipeline gains - Investing.com Canada

Nuvation Bio at citigroup biopharma summit: growth rests on three pillars - Investing.com Canada

Nuvation Bio at citigroup biopharma summit: growth rests on three pillars - Investing.com UK

NUVB: IBTROZI and safusidenib drive growth with best-in-class efficacy and expanding global opportunities - TradingView

NUVB: IBTROZI and safusidenib drive strong growth, with major clinical and commercial milestones ahead - TradingView

Jim Cramer sends strong 5-word message on surging biotech stock - Yahoo Finance

Jim Cramer sends strong 5-word message on surging biotech stock - thestreet.com

Jim Cramer: This Health Care Stock Is Pure Spec, The Only Neocloud I Like Is... - Benzinga

Cramer's lightning round: Nuvation Bio 'is a pure spec' - CNBC

Does Nuvation Bio (NUVB) Have the Potential to Rally 91.92% as Wall Street Analysts Expect? - Yahoo Finance

Does Nuvation Bio (NUVB) Have the Potential to Rally 91.92% as Wall Street Analysts Expect? - Zacks Investment Research

Nuvation Bio to Participate in Upcoming Investor Conferences - Investing News Network

Nuvation Bio to Participate in Upcoming Investor Conferences - PR Newswire

Nuvation Bio to Participate in Upcoming Investor Conferences - Yahoo Finance

Simile a NUVB

KLRA$12.460.99%

NRIX$15.0941.56%

ADRX$15.473.85%

INVA$21.362.05%

RARE$17.092.77%